Support resources and services for the use of annotated patient-derived (PD) models including xenografts (PDX) and organoids (PDO) models for research that make an impact in precision cancer medicine.
Operates across research disciplines to bring cutting-edge expertise, resources and opportunities to companies and organizations in the digital health technology sector